JAK inhibition as a therapeutic strategy for immune and inflammatory diseases

DM Schwartz, Y Kanno, A Villarino, M Ward… - Nature reviews Drug …, 2017 - nature.com
The discovery of cytokines as key drivers of immune-mediated diseases has spurred efforts
to target their associated signalling pathways. Janus kinases (JAKs) are essential signalling …
被引用次数：1261 相关文章

JAK inhibition as a therapeutic strategy for immune and inflammatory diseases

DM Schwartz, Y Kanno, A Villarino… - Nature reviews …, 2017 - scholarship.miami.edu
Proof provided by biological therapies that cytokines are truly key drivers of immune-
mediated diseases has spurred effort in targeting their associated signaling pathways. Small …

JAK inhibition as a therapeutic strategy for immune and inflammatory diseases

DM Schwartz, Y Kanno, A Villarino… - Nature Reviews Drug …, 2017 - researchgate.net
In the version of this article that was originally published, there was an error in Figure 3 on
page 847. In this figure, the structure attributed to the compound BMS-986165 is incorrect …

JAK inhibition as a therapeutic strategy for immune and inflammatory diseases.

DM Schwartz, Y Kanno, A Villarino, M Ward… - Nature reviews. Drug …, 2017 - europepmc.org
Proof provided by biological therapies that cytokines are truly key drivers of immune-
mediated diseases has spurred effort in targeting their associated signaling pathways. Small …

JAK inhibition as a therapeutic strategy for immune and inflammatory diseases

DM Schwartz, Y Kanno, A Villarino… - Nature reviews …, 2017 - pubmed.ncbi.nlm.nih.gov
The discovery of cytokines as key drivers of immune-mediated diseases has spurred efforts
to target their associated signalling pathways. Janus kinases (JAKs) are essential signalling …
[HTML] nih.gov

[HTML][HTML] JAK inhibition as a therapeutic strategy for immune and inflammatory diseases

DM Schwartz, Y Kanno, A Villarino… - Nature reviews. Drug …, 2017 - ncbi.nlm.nih.gov
Proof provided by biological therapies that cytokines are truly key drivers of immune-
mediated diseases has spurred effort in targeting their associated signaling pathways. Small …

Erratum: JAK inhibition as a therapeutic strategy for immune and inflammatory diseases

DM Schwartz, Y Kanno, A Villarino, M Ward… - Nature Reviews Drug …, 2018 - nature.com
In the version of this article that was originally published, there was an error in Figure 3 on
page 847. In this figure, the structure attributed to the compound BMS-986165 is incorrect …

[引用][C] JAK inhibition as a therapeutic strategy for immune and inflammatory diseases

DM Schwartz, Y Kanno, A Villarino, M Ward… - Nature Reviews Drug …, 2017 - cir.nii.ac.jp

JAK inhibition as a therapeutic strategy for immune and inflammatory diseases

DM Schwartz, Y Kanno, A Villarino, M Ward… - Nature Reviews Drug …, 2017 - go.gale.com
The discovery of cytokines as key drivers of immune-mediated diseases has spurred efforts
to target their associated signalling pathways. Janus kinases (JAKs) are essential signalling …

JAK inhibition as a therapeutic strategy for immune and inflammatory diseases.

DM Schwartz, Y Kanno, A Villarino, M Ward… - Nature reviews. Drug …, 2017 - europepmc.org
Proof provided by biological therapies that cytokines are truly key drivers of immune-
mediated diseases has spurred effort in targeting their associated signaling pathways. Small …